🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

26 results for “Gilead Sciences Ireland UC” Clear

  1. AZLI 75 mg two times a day (BID)/ three times a day (TID)

    Gilead Sciences Ireland UC

    Cystic Fibrosis

    phase 3 small molecule completed

    1 trial

  2. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1/HBV Co-Infection

    phase 3 small molecule completed

    1 trial

  3. B/F/TAF (Adult Strength)

    Gilead Sciences Ireland UC

    HIV-1 Infection

    phase 3 small molecule active

    1 trial

  4. Bictegravir

    Gilead Sciences Ireland UC

    HIV-1-infection

    phase 3 small molecule active

    2 trials

  5. COBI

    Gilead Sciences Ireland UC

    HIV

    phase 3 small molecule completed

    1 trial

  6. E/C/F/TDF

    Gilead Sciences Ireland UC

    Acquired Immunodeficiency Syndrome

    phase 3 small molecule completed

    1 trial

  7. LDV/SOF

    Gilead Sciences Ireland UC

    Hepatitis C Virus

    phase 3 small molecule completed

    1 trial

  8. SOF/VEL

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    3 trials

  9. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    1 trial

  10. Sacituzumab Govitecan-hziy

    Gilead Sciences Ireland UC

    Triple Negative Breast Cancer

    phase 3 small molecule active

    1 trial

  11. Sofosbuvir

    Gilead Sciences Ireland UC

    Hepatitis C

    phase 3 small molecule completed

    2 trials

  12. Sofosbuvir

    Gilead Sciences Ireland UC

    Chronic HCV Infection

    phase 3 small molecule completed

    1 trial

  13. Tenofovir DF

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 3 small molecule active

    1 trial

  14. Andecaliximab

    Gilead Sciences Ireland UC

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  15. BSF 208075

    Gilead Sciences Ireland UC

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  16. Presatovir

    Gilead Sciences Ireland UC

    Respiratory Syncytial Virus

    phase 2 small molecule completed

    1 trial

  17. SOF

    Gilead Sciences Ireland UC

    HCV Infection

    phase 2 small molecule completed

    1 trial

  18. SOF

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial

  19. VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial

  20. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1-infection

    phase 1 small molecule completed

    1 trial

  21. Evixapodlin

    Gilead Sciences Ireland UC

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  22. GS-0272

    Gilead Sciences Ireland UC

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial

  23. GS-2829

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial

  24. Lanraplenib.

    Gilead Sciences Ireland UC

    Inflammatory Disease

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources